U.S. Infectious Disease Molecular Diagnostics Market Size & Outlook
U.S. infectious disease molecular diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. infectious disease molecular diagnostics market highlights
- The U.S. infectious disease molecular diagnostics market generated a revenue of USD 5,807.2 million in 2024 and is expected to reach USD 7,175.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
- In terms of segment, reagents product was the largest revenue generating product in 2024.
- Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious disease molecular diagnostics market data book summary
| Market revenue in 2024 | USD 5,807.2 million |
| Market revenue in 2030 | USD 7,175.8 million |
| Growth rate | 3.6% (CAGR from 2025 to 2030) |
| Largest segment | Reagents product |
| Fastest growing segment | Others Product |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments Product, Reagents Product, Others Product |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.5% of the global infectious disease molecular diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 7,175.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.67% in 2024. Horizon Databook has segmented the U.S. infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. leads the molecular diagnostics market due to local presence of leading players, such as Roche Diagnostics, Abbott, and BD. One of the reasons for their continued dominance is presence of wellestablished R&D infrastructure and favorable reimbursement policies.
In addition, regulatory and reimbursement landscape is continuously evolving to adapt to the fast-paced research progress in this sector. Moreover, FDA is developing new regulatory strategies regarding NGS, which is anticipated to boost innovation in tests, while ensuring that the data produced by these tests are accurate and reliable.
The increase in number of COVID-19 cases is expected to aid launch of new products under the EUA, aiding growth. In March 2020, first EUA was granted to BioFire Respiratory Panel 2.1, which was followed by other products like PerkinElmer SARS-CoV-2 RT-qPCR Reagent Kit and BD SARS-CoV-2/Flu. Multidrug Resistant (MDR) bacteria are associated with nosocomial infections and are a threat to public health.
Reasons to subscribe to U.S. infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. infectious disease molecular diagnostics market size, by product, 2018-2030 (US$M)
U.S. Infectious Disease Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
